Receive Breaking News updates as they occur
Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor said on Tuesday. More charges related to Shkreli's involvement with biopharmaceutical company Retrophin Inc could be filed within a month, Assistant U.S. Attorney Winston Paes said at a hearing in federal court in Brooklyn, New York. Shkreli, 33, sparked outrage among patients, medical societies and U.S. lawmakers after another company he ran, Turing Pharmaceuticals, raised the price of the drug Daraprim by more than 5,000 percent to $750 a pill.
The Islamic State group killed a Navy SEAL during an "orchestrated attack" in Iraq on Tuesday, a US defense official said. The Pentagon had earlier announced a US troop died during an IS attack on a Peshmerga position north of Mosul. "It was an orchestrated attack with shots and multiple IEDs (bombs) going off," the official told AFP, speaking on condition of anonymity.